Pharmaceutics

Pharmacology, Toxicology and Pharmaceutical Science

1. Acetic Acid Ethyl Ester 13%
2. Anti-Inflammatory Drug 45%
3. Antibacterial Activity 20%
4. Antibiotics 14%
5. Anticarcinogen 12%
6. Antiinfective Agent 62%
7. Antiinflammatory Activity 10%
8. Antimicrobial Agent 28%
9. Antioxidant 47%
10. Antioxidant Capacity 19%
11. Antivirus Agent 10%
12. Apigenin 11%
13. Apremilast 9%
14. Bacterium 11%
15. Baricitinib 9%
16. Bioavailability 76%
17. Biological Marker 12%
18. Breast Cancer 44%
19. Carbon Dioxide 12%
20. Caspase 3 9%
21. Chitosan 36%
22. Ciprofloxacin 9%
23. Clinical Trial 11%
24. Curcumin 9%
25. Cytokine 18%
26. Cytotoxicity 53%
27. Delafloxacin 9%
28. Diabetes Mellitus 12%
29. Diethylene Glycol Monoethyl Ether 8%
30. Differential Scanning Calorimetry 22%
31. Diosmin 9%
32. Diseases 39%
33. Dosage Form 9%
34. Drug Delivery System 41%
35. Drug Development 9%
36. Drug Release 44%
37. Enzyme 18%
38. Essential Oil 21%
39. Ethanol 18%
40. Ethyl Cellulose 11%
41. Flavonoid 15%
42. Glycyrrhizin 8%
43. Gold Nanoparticle 16%
44. High Performance Liquid Chromatography 11%
45. IC50 20%
46. Infection 19%
47. Infectious Agent 12%
48. Inflammation 32%
49. Inflammatory Arthritis 10%
50. Interleukin 1 10%
51. Interleukin 6 14%
52. Lipid 40%
53. Liposome 13%
54. Lung Cancer 21%
55. Malignant Neoplasm 65%
56. Medicinal Plant 9%
57. Metformin 8%
58. Methanol 11%
59. Methicillin-Resistant Staphylococcus Aureus 13%
60. microRNA 10%
61. Nanocarrier 39%
62. Nanoemulsion 33%
63. Nanoformulation 10%
64. Nanogel 14%
65. Nanomedicine 11%
66. Nanoparticle 100%
67. Natural Product 18%
68. Neoplasm 15%
69. Non Small Cell Lung Cancer 10%
70. Parkinson's Disease 12%
71. Pathogenesis 10%
72. Pharmacodynamics 8%
73. Pharmacokinetic 53%
74. Phytochemical 27%
75. Poloxamer 17%
76. Polyglactin 12%
77. Polyvinyl Alcohol 8%
78. Propylene Glycol 8%
79. Pseudomonas aeruginosa 16%
80. Psoriasis 24%
81. Rat 53%
82. Rat Model 13%
83. Receptor 16%
84. Rheumatoid Arthritis 10%
85. Rutin 9%
86. Scanning Electron Microscopy 19%
87. Sildenafil 9%
88. Silymarin 9%
89. Simvastatin 9%
90. Skin Infection 9%
91. Solid Lipid Nanoparticle 25%
92. Staphylococcus aureus 16%
93. Surfactant 12%
94. Sustained Release 29%
95. Tablet 40%
96. Transdermal 9%
97. Tumor Necrosis Factor 15%
98. Untranslated RNA 12%
99. Wound Healing 22%
100. Zeta Potential 36%